ArticleDrugs in context2018
Eosinophilic fasciitis: a case series with an emphasis on therapy and induction of remission.
Article in Drugs in context, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 16 citations in OpenAlex.
- [Eosinophilic fascitis: A case report and literature review].Revista medica del Instituto Mexicano del Seguro Social · 2026Review
- Unilateral Eosinophilic Fasciitis With Hand Involvement: A Case Report.Clinical case reports · 2025Article
- Tocilizumab in the Treatment of Eosinophilic Fasciitis: A Case Study and Review of Literature.Mediterranean journal of rheumatology · 2023Review
- UVA-1 phototherapy as adjuvant treatment for eosinophilic fasciitis: in vitro and in vivo functional characterization.International journal of dermatology · 2022Article
- Eosinophilic fasciitis in a pregnant woman with corticosteroid dependence and good response to infliximab.Rheumatology international · 2021Article
- Refractory eosinophilic fasciitis successfully treated with infliximab: A case report.Journal of scleroderma and related disorders · 2021Article
- Mycophenolate Mofetil for Eosinophilic Fasciitis: A Retrospective Analysis From 3 Tertiary Care Centers.JAMA dermatology · 2020Article
- The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review.Clinical rheumatology · 2020Review
- Eosinophilic Fasciitis - Report of Three Cases and Review of the Literature.Open access Macedonian journal of medical sciences · 2019Article
- Eosinophilic Fasciitis Presenting as an Ichthyosiform Eruption of the Bilateral Ankles.Case reports in dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic fasciitis is an uncommon connective tissue disorder that affects patients of all ages, resulting in significant morbidity. Systemic corticosteroids can induce remission of disease. However, there is no universally accepted treatment ladder for eosinophilic fasciitis. This case series evaluates treatment efficacy in patients with eosinophilic fasciitis seen at Wake Forest University Department of Dermatology outpatient clinics. Patient charts were screened using ICD-9 diagnosis code 710.9 (unspecified diffuse connective tissue disease) to identify patients with eosinophilic fasciitis (n=10) seen at our institution. Patients were treated for an average 24 months with a combination of methotrexate and prednisone therapy, unless one or both were contraindicated, with each medication tapered conservatively to prevent disease flares. Alternate treatments included mycophenolate mofetil with prednisone, azathioprine with prednisone, prednisone monotherapy, and methotrexate monotherapy. Disease remission off therapy and on low-dose therapy was 66 and 70%, respectively. Our first-line therapy of concomitant methotrexate and prednisone is well-tolerated and effective for managing patients with eosinophilic fasciitis. Our study was limited to cases seen at a single academic institution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.